Inadequate control of the contact phase activation and subsequent kinin overproduction give rise to HAE [2], [4], [6] primarily attributed to a genetic deficiency (HAE I) or dysfunction (HAE II) of C1-Inhibitor (C1INH). The gene discussed is SERPING1; the disease is hereditary angioedema.